Report an error

Spotted something inaccurate in “MC4R Agonist Setmelanotide Reduces Hypothalamic Obesity in Phase III Trial”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.